Results 231 to 240 of about 3,005,072 (284)

Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Evaluate whether proteinuria levels, in women undergoing expectant management for pre‐eclampsia, are associated with pregnancy latency and adverse outcomes. Design Secondary analysis of data from two randomised trials. Setting Tygerberg Hospital, Cape Town, South Africa.
Amy van Rooyen, Lina Bergman, Henrik Imberg, Denise Sproul, Susan P. Walker, Stephen Tong, Catherine A. Cluver   +6 more
wiley   +1 more source

Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan, Nazli Tunali, R. Andrew Chambers   +2 more
wiley   +1 more source

revelstoke_yearbook_1963 [PDF]

, 1963

core  

Efficacy of Full and Limited Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Randomised Controlled Trial

Allergy, EarlyView.
Both Full and Limited FESS result in clinically meaningful relief of disease‐specific HRQoL and nasal breathing, effectively improving nasal symptoms and sleep disturbance in CRSwNP patients. Clinically meaningful difference in decrease of SNOT‐22 scores between the groups was not found at 12‐ and 24–month follow‐up.
P. Virkkula, S. Hammarén‐Malmi, A. Laulajainen‐Hongisto, M. Lilja, J. Wikstén, L. Hafrén, P. Kauppi, S. Reitsma, K. Pajala, J. Sahlman, S. Toppila‐Salmi   +10 more
wiley   +1 more source

revelstoke_yearbook_1985 [PDF]

, 1985

core  

[Secondary immunodeficiency and infection].

Nihon saikingaku zasshi. Japanese journal of bacteriology, 1982
openaire   +1 more source

[Secondary Immunodeficiency in Rheumatology].

Therapeutische Umschau. Revue therapeutique, 2022
Secondary Immunodeficiency in Rheumatology Abstract. For the treatment of autoimmune and autoinflammatory diseases an immunosuppressive therapy with conventional, small molecule or biological disease modifying anti-rheumatic drugs (DMARDS) plays a key role.
Javet, Adrienn, Maurer, Britta
openaire   +4 more sources

Secondary immunodeficiency in lymphoproliferative malignancies

Hematological Oncology, 2016
AbstractSecondary immunodeficiencies occur as a consequence of various diseases, including hematological malignancies, and the use of pharmacological therapies, such as immunosuppressive, anti‐inflammatory, and biological drugs. Infections are the main cause of morbidity and mortality in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL ...
Friman, V, Winqvist, O, Blimark, C, Langerbeins, P, Chapel, H, Dhalla, F   +5 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Immunodeficiency secondary to biologics

Journal of Allergy and Clinical Immunology, 2023
Elie Haddad, Roxane Labrosse
exaly   +3 more sources

Primary and Secondary Immunodeficiency

2021
exaly   +2 more sources